
SELECTED STUDIES
Section Editor: Prof. Talaat I. Farag
With the improvement of health care and longer lifespan of Down Syndrome persons, neuroscientists are studying the neuropathological and neurochemical basis of cognition in Down syndrome, and are interested in avoiding the decline of cognitive skills at older age.
It is well known that modalities for cognitive retraining may help patients to overcome their cognitive deficit. Rehearsal training can be used to improve working memory, and learning abilities in Down syndrome. Anti-Alzheimer medication may be a potential treatment for cognitive decline; however, further studies are required to confirm their usefulness. Here we present the profile of possible cognitive deficit in Downs syndrome, and briefly discusses both the medicinal and rehabilitative therapies.
Moreover, patients with Down syndrome have potential risk of developing cognitive deterioration that starts after the age of 35 years. The neuropathological and neurochemical changes with age in DS are indistinguishable from Alzheimer disease. The type, and distribution of senile plaques and neurofibrillary tangles, and the pattern of atrophy of the neuronal systems are qualitatively, but not quantitatively the same as those of Alzheimer disease (Mann, 1988).
Explicit memory is defined as conscious recollection of information:
Explicit Memory can be classified as shown in the following Scheme

Implicit /Procedural Memory in Downs Syndrome
• Music therapy: recent research suggested an effect for music on verbal learning ( Peterson and Thaut, 2007), However, no recent data in Down syndrome, few old studies tested the effect of music in this group (Stratford and Ching, 1989).
acetylcholinesterase inhibitors among patients with Down syndrome.